ApicHope Pharmaceutical Hits Day Low Amid Price Pressure, Closing at CNY 30.80

ApicHope Pharmaceutical Co., a large-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock declining by 4.37% as of March 3, 2026. The stock reached an intraday low of CNY 30.80, reflecting ongoing challenges within the company. Over the past week, ApicHope's performance has been notably poor, with a decrease of 6.03%, contrasting sharply with the China Shanghai Composite's modest gain of 0.41%. The company's struggles are further highlighted by its one-month performance, down 8.78%, and a year-to-date decline of 8.05%. Despite a strong annual performance of 58.21%, the long-term outlook appears concerning, with a three-year decline of 33.23% and a five-year drop of 36.65%. Financial metrics indicate a troubling trend, including a significant decrease in net sales, which fell by 39.41% to CNY 372.85 million, and a negative operating cash flow of CNY -558.24 million. The company's return on equity stands at -24.75%, underscoring the financial difficulties it faces.